Cara Therapeutics (CARA) Insider Trading & Ownership $5.13 -0.07 (-1.35%) As of 02:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cara Therapeutics (NASDAQ:CARA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$5,232.84 Get CARA Insider Trade Alerts Want to know when executives and insiders are buying or selling Cara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CARA Insider Buying and Selling by Quarter Cara Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/2/2024Christopher PosnerCEOSell328$9.00$2,952.00 4/5/2024Joana GoncalvesInsiderSell229$9.96$2,280.84 (Data available from 1/1/2013 forward) CARA Insider Trading Activity - Frequently Asked Questions Who is on Cara Therapeutics's Insider Roster? The list of insiders at Cara Therapeutics includes Christopher Posner, Frederique Ph.D. Menzaghi, Jeffrey L Ives, Joana Goncalves, Martin Vogelbaum, Ryan D Maynard, Scott Terrillion, and Thomas Charles Reilly. Learn more on insiders at CARA. What percentage of Cara Therapeutics stock is owned by insiders? 3.10% of Cara Therapeutics stock is owned by insiders. Learn more on CARA's insider holdings. Which Cara Therapeutics insiders have been selling company stock? The following insiders have sold CARA shares in the last 24 months: Christopher Posner ($59,358.60), Frederique Ph.D. Menzaghi ($23,862.72), Joana Goncalves ($2,280.84), Ryan D Maynard ($2,906.52), and Scott Terrillion ($24,929.16). How much insider selling is happening at Cara Therapeutics? Insiders have sold a total of 6,924 Cara Therapeutics shares in the last 24 months for a total of $113,337.84 sold. Cara Therapeutics Key ExecutivesMr. Christopher A. Posner (Age 54)President, CEO & Director Compensation: $1.15MMr. Ryan D. Maynard (Age 55)Chief Financial Officer Compensation: $670.7kDr. Derek T. Chalmers D.Sc. (Age 60)Ph.D., Co-Founder & Senior Advisor Compensation: $580.93kMr. Scott M. Terrillion (Age 61)Chief Compliance Officer, General Counsel & Corporate Secretary Compensation: $689.63kMr. Matthew MurphyManager of Investor Relations More Insider Trading Tools from MarketBeat Related Companies MediciNova Insider Buying Alto Neuroscience Insider Buying Metagenomi Insider Buying HilleVax Insider Buying Skye Bioscience Insider Buying Inozyme Pharma Insider Buying Jasper Therapeutics Insider Buying Entera Bio Insider Buying Elutia Insider Buying Oramed Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles META Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying Signals This page (NASDAQ:CARA) was last updated on 2/18/2025 by MarketBeat.com Staff From Our PartnersTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.